Get started
GSK plcGSK plcGSK plc

GSK plc

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsETFsBonds
Full chart
Full chart

Compare with GSK plc



Key facts today


GSK halted camlipixant for refractory chronic cough after two late‑stage trials had mixed results, removing a key readout and shifting near‑term development focus to other assets, including oncology. 1
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪76.77 B‬ GBP
Dividend yield (indicated)
3.65%
Price to earnings Ratio (TTM)
13.5
Basic EPS (TTM)
1.5 GBP
Net income (FY)
‪5.72 B‬ GBP
Revenue (FY)
‪32.67 B‬ GBP
Shares float
‪3.88 B‬
Beta (1Y)
1.22

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪66.84 K‬
Change (1Y)
‪−1.79 K‬−2.61%
Revenue / Employee (1Y)
‪488.73 K‬ GBP
Net income / Employee (1Y)
‪85.52 K‬ GBP

Profile


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Luke Miels
Website
gsk.com
Headquarters
London
IPO date
May 22, 1972
ISIN
GB00BN7SWP63
FIGI
BBG000CT5GJ1
Identifiers
ISIN GB00BN7SWP63
CFI code
ESVUFR
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


6.155% YTM
Maturity dateApr 10, 2042
Coupon5.25% (Fixed)
5.977% YTM
Maturity dateMar 9, 2039
Coupon6.38% (Fixed)
5.643% YTM
Maturity dateMar 18, 2043
Coupon4.20% (Fixed)
5.571% YTM
Maturity dateMay 12, 2035
Coupon1.63% (Fixed)
5.380% YTM
Maturity dateMay 15, 2038
Coupon6.38% (Fixed)
5.151% YTM
Maturity dateApr 15, 2035
Coupon4.88% (Fixed)
5.131% YTM
Maturity dateDec 19, 2033
Coupon5.25% (Fixed)
4.753% YTM
Maturity dateOct 12, 2028
Coupon1.25% (Fixed)
4.582% YTM
Maturity dateApr 15, 2030
Coupon4.50% (Fixed)
4.531% YTM
Maturity dateJun 1, 2029
Coupon3.38% (Fixed)
4.329% YTM
Maturity dateMay 15, 2028
Coupon3.88% (Fixed)

See all GSK bonds 

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight0.23%
Market value‪1.54 B‬
VEA
Vanguard FTSE Developed Markets ETF
Weight0.32%
Market value‪1.02 B‬
IEFA
iShares Core MSCI EAFE ETF
Weight0.41%
Market value‪751.48 M‬
ISFD
iShares PLC - iShares Core FTSE 100 UCITS ETF Accum Hedged USD
Weight2.98%
Market value‪645.83 M‬
ISF
iShares Core FTSE 100 UCITS ETF GBP (Dist)
Weight2.98%
Market value‪645.83 M‬
CEB4
iShares Core FTSE 100 UCITS ETF Accum Shs Hedged EUR
Weight2.98%
Market value‪645.83 M‬
EFA
iShares MSCI EAFE ETF
Weight0.48%
Market value‪359.48 M‬
VUKE
Vanguard FTSE 100 UCITS ETF
Weight2.97%
Market value‪270.15 M‬
VUKG
Vanguard Funds PLC - Vanguard FTSE 100 UCITS ETF AccumGBP
Weight2.97%
Market value‪270.15 M‬
VGK
Vanguard FTSEEuropean ETF
Weight0.66%
Market value‪251.76 M‬
VEU
Vanguard FTSE All World Ex US ETF
Weight0.25%
Market value‪245.13 M‬

Explore more ETFs 

Frequently asked questions


The current price of GSK is 1,893.0 GBX — it has decreased by −1.22% in the past 24 hours. Watch GSK plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange GSK plc stocks are traded under the ticker GSK.
GSK stock has fallen by −4.96% compared to the previous week, the month change is a −3.48% fall, over the last year GSK plc has showed a 40.43% increase.
We've gathered analysts' opinions on GSK plc future price: according to them, GSK price has a max estimate of 2,825.00 GBX and a min estimate of 1,700.00 GBX. Watch GSK chart and read a more detailed GSK plc stock forecast: see what analysts think of GSK plc and suggest that you do with its stocks.
GSK reached its all-time high on Jan 8, 1999 with the price of 2,356.5 GBX, and its all-time low was 740.5 GBX and was reached on Sep 22, 1995. View more price dynamics on GSK chart.
See other stocks reaching their highest and lowest prices.
GSK stock is 3.38% volatile and has beta coefficient of 1.22. Track GSK plc stock price on the chart and check out the list of the most volatile stocks — is GSK plc there?
Today GSK plc has the market capitalization of ‪78.35 B‬, it has decreased by −1.89% over the last week.
Yes, you can track GSK plc financials in yearly and quarterly reports right on TradingView.
GSK plc is going to release the next earnings report on Jul 28, 2026. Keep track of upcoming events with our Earnings Calendar.
GSK earnings for the last quarter are 0.47 GBX per share, whereas the estimation was 0.43 GBX resulting in a 7.86% surprise. The estimated earnings for the next quarter are 0.46 GBX per share. See more details about GSK plc earnings.
GSK plc revenue for the last quarter amounts to ‪7.63 B‬ GBX, despite the estimated figure of ‪7.63 B‬ GBX. In the next quarter, revenue is expected to reach ‪8.26 B‬ GBX.
GSK net income for the last quarter is ‪1.74 B‬ GBP, while the quarter before that showed ‪636.00 M‬ GBP of net income which accounts for 0.00% change. Track more GSK plc financial stats to get the full picture.
Yes, GSK dividends are paid quarterly. The last dividend per share was 0.17 GBP. As of today, Dividend Yield (TTM)% is 3.43%. Tracking GSK plc dividends might help you take more informed decisions.
GSK plc dividend yield was 3.62% in 2025, and payout ratio reached 46.78%. The year before the numbers were 4.53% and 96.58% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 21, 2026, the company has ‪66.84 K‬ employees. See our rating of the largest employees — is GSK plc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GSK plc EBITDA is ‪11.19 B‬ GBP, and current EBITDA margin is 32.24%. See more stats in GSK plc financial statements.
Like other stocks, GSK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GSK plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GSK plc technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GSK plc stock shows the buy signal. See more of GSK plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.